---
figid: PMC9392712__535_2022_1889_Fig2_HTML
figtitle: Targeting autophagy as a therapeutic strategy against pancreatic cancer
organisms:
- NA
pmcid: PMC9392712
filename: 535_2022_1889_Fig2_HTML.jpg
figlink: /pmc/articles/PMC9392712/figure/Fig2/
number: F2
caption: 'Overview of the general autophagy pathway in mammalian cells. (Bottom) Autophagy
  can be divided into five major steps: (1) Initiation and nucleation of the double-membrane
  phagophore, (2) elongation and (3) closure of the phagophore to form the autophagosome,
  (4) autophagosome-lysosome fusion, and (5) lysosomal degradation and nutrient recycling.
  (Top left) Autophagy induction is primarily mediated by the ULK1 complex, which
  is regulated by AMPK and mTORC1. Upon activation, the ULK1 complex activates the
  class III phosphatidylinositol 3-kinase (PI3K) complex through phosphorylation of
  beclin 1 (BECN1) and VPS34. The Class III PI3K complex generates PI3P at the site
  of nucleation of phagophore from ER. (Top middle) ProLC3B is converted to LC3B-I
  via the cleavage by ATG4B. LC3B-I is conjugated with PE through ubiquitin-like conjugation
  systems that include ATG7 (E1 ligase), ATG3 (E2 ligase), and ATG12, ATG5, and ATG16L
  (the E3 ligase complex). The resulting PE-conjugated LC3, which is called LC3B-II
  (shown as small green circles), is inserted on the phagophore membranes, where it
  facilitates phagophore elongation and closure. (Pale blue frames) Inhibitors of
  ULK1/2 (SBI-0206965 [], MRT68921, MRT 67,307 [], ULK101 []), VPS34 (VPS34-In1 [],
  PIK-III [], SAR405 [], Compound 31 [], Spautin1 []), ATG4B (S130 [], FMK-9a [],
  NSC185058 []), and the lysosome [CQ/HCQ, BafA1, Lys05 []]) are shown. ULK Unc-51-like
  kinase, PI3K phosphatidylinositol 3-kinase, PI3P phosphatidylinositol 3-phosphate,
  ER endoplasmic reticulum, WIPI WD-repeat protein interacting with phosphoinositide,
  mTORC1 mammalian target of rapamycin complex 1, AMPK 5'' AMP-activated protein kinase,
  PE phosphatidylethanolamine, p62/SQSTM1 sequestosome 1, NBR1 neighbor of BRCA1'
papertitle: Targeting autophagy as a therapeutic strategy against pancreatic cancer.
reftext: Keisuke Yamamoto, et al. J Gastroenterol. 2022;57(9):603-618.
year: '2022'
doi: 10.1007/s00535-022-01889-1
journal_title: Journal of Gastroenterology
journal_nlm_ta: J Gastroenterol
publisher_name: Springer Nature Singapore
keywords: PDAC | Autophagy | Lysosome | Host autophagy | Anti-tumor immunity
automl_pathway: 0.9453717
figid_alias: PMC9392712__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC9392712__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9392712__535_2022_1889_Fig2_HTML.html
  '@type': Dataset
  description: 'Overview of the general autophagy pathway in mammalian cells. (Bottom)
    Autophagy can be divided into five major steps: (1) Initiation and nucleation
    of the double-membrane phagophore, (2) elongation and (3) closure of the phagophore
    to form the autophagosome, (4) autophagosome-lysosome fusion, and (5) lysosomal
    degradation and nutrient recycling. (Top left) Autophagy induction is primarily
    mediated by the ULK1 complex, which is regulated by AMPK and mTORC1. Upon activation,
    the ULK1 complex activates the class III phosphatidylinositol 3-kinase (PI3K)
    complex through phosphorylation of beclin 1 (BECN1) and VPS34. The Class III PI3K
    complex generates PI3P at the site of nucleation of phagophore from ER. (Top middle)
    ProLC3B is converted to LC3B-I via the cleavage by ATG4B. LC3B-I is conjugated
    with PE through ubiquitin-like conjugation systems that include ATG7 (E1 ligase),
    ATG3 (E2 ligase), and ATG12, ATG5, and ATG16L (the E3 ligase complex). The resulting
    PE-conjugated LC3, which is called LC3B-II (shown as small green circles), is
    inserted on the phagophore membranes, where it facilitates phagophore elongation
    and closure. (Pale blue frames) Inhibitors of ULK1/2 (SBI-0206965 [], MRT68921,
    MRT 67,307 [], ULK101 []), VPS34 (VPS34-In1 [], PIK-III [], SAR405 [], Compound
    31 [], Spautin1 []), ATG4B (S130 [], FMK-9a [], NSC185058 []), and the lysosome
    [CQ/HCQ, BafA1, Lys05 []]) are shown. ULK Unc-51-like kinase, PI3K phosphatidylinositol
    3-kinase, PI3P phosphatidylinositol 3-phosphate, ER endoplasmic reticulum, WIPI
    WD-repeat protein interacting with phosphoinositide, mTORC1 mammalian target of
    rapamycin complex 1, AMPK 5'' AMP-activated protein kinase, PE phosphatidylethanolamine,
    p62/SQSTM1 sequestosome 1, NBR1 neighbor of BRCA1'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Crtc
  - SNF4Agamma
  - AMPKalpha
  - Atg1
  - Low
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Atg13
  - Atg17
  - Atg101
  - Atg6
  - Atg14
  - Vps15
  - Atg4b
  - pe
  - E3
  - Atg7
  - Atg3
  - Atg12
  - Atg5
  - MTOR
  - RPTOR
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - PIK3CG
  - ULK1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ATG13
  - RB1CC1
  - ATG101
  - BECN1
  - PIK3C3
  - ATG14
  - ATG4B
  - MAP1LC3B
  - ATG7
  - ATG3
  - ATG12
  - ATG5
  - ATG16L1
---
